In the scratch test, the addition of VEGF enhanced control MVECs migration (Figure 1I) and resulted in 51.34 ± 8.64% wound closure in 24 hours versus 3.86 ± 0.62% in unstimulated control (Figure 1J; P < 0.01), while no significant response was seen in VEGF‐treated SSc‐MVECs with 5.02 ± 0.98% wound closure versus 3.62 ± 0.65% in untreated SSc‐MVECs. The gene discussed is VEGFA; the disease is systemic sclerosis.